Toxicity of weekly liposomial doxorubicin and paclitaxel in metastatic breast cancer (MBC): 24 months update

被引：0
|
作者：
Di Seri, M. [1 ]
Girolami, M. [1 ]
Rosati, M. S. [1 ]
Basile, M. L. [1 ]
Ricciardi, S. [1 ]
Messina, C. G. M. [1 ]
Pellegrini, P. [1 ]
Tomao, F. [1 ]
De Biasio, L. [1 ]
Longo, F. [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Surg, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：15 / 15
页数：1
相关论文
共 50 条
  • [1] TOXICITY OF WEEKLY LIPOSOMAL DOXORUBICIN AND PACLITAXEL IN METASTATIC BREAST CANCER (MBC)
    Longo, F.
    Pellegrini, P.
    Ceccarelli, F.
    Borgomastro, A.
    Comito, T.
    Basile, M. L.
    De Biasio, G.
    Girolami, M.
    Spalletta, B.
    Di Seri, M.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 23 - 23
  • [2] Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer
    Schwonzen, M
    Kurbacher, CM
    Mallmann, P
    [J]. ANTI-CANCER DRUGS, 2000, 11 (09) : 681 - 685
  • [3] PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) AND WEEKLY PACLITAXEL (T) AS FIRST-LINE TREATMENT IN METASTATIC BREAST CANCER (MBC)
    Badalamenti, Giuseppe
    Valerio, Maria Rosaria
    Rinaldi, Gaetana
    Arcara, Carlo
    Cicero, Giuseppe
    Vizzini, Laura
    Travagliato, Maria Grazia
    Intrivici, Chiara
    Russo, Antonio
    Gulotta, Gaspare
    Gebbia, Nicola
    Fulfaro, Fabio
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 24 - 24
  • [4] Weekly paclitaxel (T) and pegylated liposomal doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.
    Fulfaro, F
    Valerio, MR
    Badalamenti, G
    Arcara, C
    Cicero, G
    Intrivici, C
    Crosta, A
    Sciortino, C
    Russo, A
    Gebbia, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 53S - 53S
  • [5] Weekly paclitaxel in metastatic breast cancer
    Chang, AY
    Rubins, J
    Asbury, R
    Boros, L
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (06) : 7 - 7
  • [6] Severe skin toxicity observed in patients (pts) treated with capecitabine (CAP) and weekly paclitaxel (PACLI) for metastatic breast cancer (MBC)
    Zdrale, Z.
    Matijasevic, M.
    [J]. EJC SUPPLEMENTS, 2008, 6 (07): : 200 - 200
  • [7] Paclitaxel and doxorubicin in metastatic breast cancer
    Gehl, J
    Boesgaard, M
    Paaske, T
    Jensen, BV
    Dombernowsky, P
    [J]. SEMINARS IN ONCOLOGY, 1996, 23 (06) : 35 - 38
  • [8] Weekly paclitaxel and pegylated liposomal doxorubicin in metastatic breast carcinoma
    Leonardi, V.
    Palmisano, V.
    Pepe, A.
    Usset, A.
    Savio, G.
    Laudani, A.
    Calabria, C.
    Tartaglia, L.
    Amari, P.
    Carruba, G.
    Agostara, B.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 55 - 55
  • [9] Bi-weekly administration of pegylated liposomal doxorubicin plus paclitaxel in metastatic breast cancer (MBC) patients: A phase II study.
    Simoncini, E
    Ferrari, VD
    Amoroso, V
    Valcamonico, F
    Grisanti, S
    Vassalli, L
    Marpicati, P
    Montini, E
    Rangoni, G
    Marini, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 88S - 88S
  • [10] Age-Related Changes in the Pharmacokinetics (pK), Response, and Toxicity of Weekly nab-Paclitaxel in Patients with Metastatic Breast Cancer (MBC)
    Hurria, A.
    Synold, T.
    Blanchard, S.
    Wong, C.
    Mortimer, J.
    Luu, T.
    Chung, C.
    Ramani, R.
    Katheria, V.
    Hansen, K.
    Jayani, R.
    Brown, J.
    Williams, B.
    Rotter, A.
    Somlo, G.
    [J]. CANCER RESEARCH, 2011, 71
12345